Plain-English translation of NCT06496659 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing whether segmentectomy โ a smaller type of lung surgery that removes only a small section of the lung โ is safe and works well for patients whose advanced lung cancer has shrunk after receiving chemotherapy and immunotherapy treatments beforehand. Right now, doctors aren't sure if this smaller surgery is appropriate for patients whose cancer started out advanced but got smaller, even though smaller surgeries tend to help patients with early-stage lung cancer live longer and feel better.
Recent treatments like chemotherapy and immunotherapy have become very good at shrinking advanced lung cancers down to a smaller size. At the same time, research shows that smaller lung surgeries lead to better long-term survival and quality of life compared to removing an entire lung section โ but doctors have not yet studied whether this smaller surgery is safe for patients whose cancers started advanced and were then shrunk by treatment.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this trial, you will undergo segmentectomy surgery โ a procedure where surgeons remove only the affected segment of your lung rather than removing an entire lung section. Your surgical team will carefully monitor whether the surgery successfully removes all cancer and whether you recover well without needing to convert to a larger operation. The trial will enroll about 25 patients total to determine whether this smaller surgery is both safe and effective for people like you whose cancer has responded well to chemotherapy and immunotherapy.
AI-generated summary from trial data ยท Jun 12, 2026 ยท Not medical advice
United States
Sponsor
Northwestern University
Collaborators
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Enrollment target
~25 participants
Started
August 2024
Primary completion
July 2029
Age range
18 Years โ 89 Years
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Ankit Bharat, M.D.
Northwestern University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.